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Abstract
Background:   Termination of translation in eukaryotes is controlled by two interacting
polypeptide chain release factors, eRFl and eRF3. eRFl recognizes nonsense codons UAA, UAG and
UGA, while eRF3 stimulates polypeptide release from the ribosome in a GTP- and eRFl –
dependent manner. Recent studies has shown that proteins interacting with these release factors
can modulate the efficiency of nonsense codon readthrough.
Results:  We have isolated a nonessential yeast gene, which causes suppression of nonsense
mutations, being in a multicopy state. This gene encodes a protein designated Itt1p, possessing a
zinc finger domain characteristic of the TRIAD proteins of higher eukaryotes. Overexpression of
Itt1p decreases the efficiency of translation termination, resulting in the readthrough of all three
types of nonsense codons. Itt1p interacts in vitro with both eRFl and eRF3. Overexpression of eRFl,
but not of eRF3, abolishes the nonsense suppressor effect of overexpressed Itt1p.
Conclusions:  The data obtained demonstrate that Itt1p can modulate the efficiency of translation
termination in yeast. This protein possesses a zinc finger domain characteristic of the TRIAD
proteins of higher eukaryotes, and this is a first observation of such protein being involved in
translation.
Background
The final step of protein biosynthesis represents the ter-
mination codon-dependent release of a nascent complet-
ed peptide chain from the ribosome. In eukaryotes, this
process is controlled by two protein factors: eRFl, recog-
nizing all three types of nonsense codons, and eRF3,
which stimulates polypeptide release in a GTP- and eR-
Fl- dependent manner [1–3]. In the yeast Saccharomy-
ces cerevisiae, the eRFl and eRF3 release factors are
encoded by the SUP45 and SUP35 genes, respectively,
and are often designated as the Sup45 and Sup35 pro-
teins [4]. Partial inactivation of these release factors by
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mutations results in enhanced nonsense codon
readthrough, which can be revealed in yeast by suppres-
sion of nonsense mutations, while deletions of the corre-
sponding genes are lethal. It was shown for vertebrates
and yeast that eRF3 and eRFl interact with each other to
form a heterodimeric complex both in vivo and in vit-
ro[2,4–6]. Yeast eRF3 has a complex structure and is
composed of the amino-terminal region and carboxy-
terminal (C) domain of 253 and 432 amino acids, respec-
tively [7–9]. The conserved C domain of Sup35p is re-
sponsible for its function in translation termination and
is essential for cell viability, while the N-terminal region
is neither conserved, nor essential. This region may be
further subdivided into the middle (M) domain of un-
known function and N-terminal (N) domain of 123 ami-
no acids, which is responsible for the prion properties of
eRF3.
In human cells, eRFl, being in excess, enhances the effi-
ciency of translation termination, which is consistent
with its function in translation [10]. However, in yeast
only simultaneous overexpression of both release factors
is required for the antisuppressor effect [4], suggesting
that a complex of these factors is active in vivo in trans-
lation termination.
Premature termination of translation is not the only con-
sequence of the occurrence of nonsense mutations: they
can also enhance decay rate of the corresponding mRNA
(Nonsense Mediated Decay; NMD). This phenomenon
has been observed in both prokaryotic and eukaryotic
cells. Several factors involved in NMD have been identi-
fied in yeast S. cerevisiae. Among them, the UPF1, UPF2,
and UPF3 genes are characterized best [for review, see
[11]]. Mutations in these genes selectively stabilize mR-
NAs containing early nonsense codons without affecting
the decay rate of most wild-type mRNAs. These muta-
tions manifest themselves as nonsense suppressors and
initially it was concluded that the suppression was solely
due to the increase of abundance of nonsense-containing
mRNAs and corresponding readthrough proteins. How-
ever, later it was demonstrated that it is not so and non-
sense suppression was due to the impaired ability of Upf1
protein to enhance translation termination at nonsense
codons. The upf1 mutations were identified that sup-
press nonsense mutations, but do not stabilize nonsense
codon-containing mRNAs [12,13]. The involvement of
the Upf1 protein in translation termination was con-
firmed by the finding that it physically interacts with
both eRF1 and eRF3 [14]. Recent data indicate that
Upf2p and Upf3p are also involved in the control of
translation termination serving as activators of Upf1p
function [15]. Upf1p contains a cysteine- and histidine-
rich region near its amino terminus and all the motifs
characteristic of the superfamily group I helicases
[12,13]. Another member of this protein superfamily,
Mtt1p, whose overexpression enhances the level of non-
sense codon readthrough, was recently identified [16].
This protein also interacts with the translation termina-
tion factors, but in contrast to Upf1p is not involved in
the control of NMD and exerts an opposite effect on
translation termination.
Here we present a study directed for identification of ad-
ditional proteins involved in translation termination in
yeast. A screen for multicopy nonsense suppressors re-
vealed a novel protein that inhibits translation termina-
tion by binding to polypeptide chain release factors.
Interestingly, this protein belongs to a recently described
class of TRIAD zinc finger proteins, many of which are
presumed to be involved in transcription.
Results
Isolation and characterization of the ITT1 gene
S. cerevisiae strain 2G-DM8, carrying the non-suppress-
ible ura3-52 mutation and nonsense mutations his7-1
(UAA), trp1-289 (UAG) and lys2-187 (UGA) was trans-
formed with the yeast genomic library. The transform-
ants were then replica plated on the media selective for
the plasmid marker URA3 and lacking histidine, tryp-
tophane or lysine. Fifty transformants able to grow on ei-
ther one of these media were selected. Only one of them
grew on all media. The plasmid-less Ura- colonies ap-
pearing after streaking this transformant on YPD medi-
um, became His-, Trp- and Lys-, which confirmed that
suppressor phenotype of the transformant depended on
the presence of plasmid.
Plasmid DNA recovered from this transformant carried a
genomic DNA insert of approximately 5 kb. The se-
quence responsible for multicopy suppression was de-
limited to a XbaI-HindIII region of 2.7 kb. Sequencing of
this fragment showed that it contains the open reading
frame (ORF) YML068w (GenBank # CAA86252.1),
which encodes a polypeptide of 464 amino acids with es-
timated molecular mass of 54 kDa. No function was as-
cribed to this ORF, which we designated as ITT1
(Inhibitor of Translation Termination). The codon adap-
tation index (CAI) of the ITT1 gene (Yeast Protein Data-
base) is 0.127, which suggests that this gene is expressed
at low levels. The deduced Itt1 protein possesses a zinc
finger domain. This domain starts from residue 180 and
belongs to a recently described TRIAD family [17]. It in-
cludes three double zinc fingers: a RING C3HC4 element
followed by two elements of C6HC and C7HC structure. A
search for Itt1p homologues revealed 8 proteins in
Caenorhabditis elegans and 8 proteins in man with sim-
ilarity ranging from 20 to 35% (Figure 1). S. cerevisiae
has one more TRIAD protein, YKR017c, but its similarity
to Itt1p is lower than that of some TRIAD proteins fromBMC Molecular Biology 2001, 2:9 http://www.biomedcentral.com/1471-2199/2/9
man and C elegans. Although the TRIAD proteins are not
well characterized, conservation of the TRIAD zinc fin-
gers suggests that they may have important functions
(see Discussion).
To characterize the Itt1p function, the diploid strain H8
was disrupted for ITT1. The obtained strain was sporu-
lated, and tetrads were dissected. The 2+:2- segregation
for the LEU2 disruption marker observed for 39 tetrads
analyzed demonstrated that the ITT1 gene is not essen-
tial for viability. Curiously, despite this gene being ines-
sential, our attempts to disrupt it in a haploid strain were
unsuccessful.
To quantify the suppressor effect of overexpressed Itt1p,
the 1A-H8-B2 psi - strain, carrying the itt1::LEU2 dis-
ruption, was transformed with either multicopy
YEplac112-ITT1 or centromeric YCplac22-ITT1 plas-
mids. Northern blot analysis revealed that amount of
ITT1 mRNA in the transformant with multicopy plasmid
increased approximately 10-fold compared to the trans-
formant with centromeric one (data not shown). Overex-
pression of Itt1p increased the readthrough levels of all
types of stop codons, which confirms omnipotence of the
ITT1 multicopy suppression (Figure 2). The levels of
nonsense suppression did not noticeably depend on the
presence of wild-type ITT1 gene. Similar data were ob-
tained for the strain with enhanced level of nonsense
suppression due to deletion of UPF1 (data not shown).
Itt1p interacts with eRF1 and eRF3
The inhibition of translation termination by excess Itt1p
could be due to decreased levels of release factors. How-
ever, neither extra copies, nor deletion of the ITT1 gene
affected the abundance of eRF1 and eRF3 (data not
shown). Itt1p could also inhibit termination by binding
to the eRF1 and eRF3 release factors. To examine the in-
teraction of Itt1p with eRF1 and eRF3, we studied the
ability of immobilized Itt1p to bind purified eRF1 and
eRF3. These proteins were individually expressed in E.
coli as fusions with either 6-histidine or GST tags. Also,
we used eRF3 expressed in yeast as GST-eRF3 fusion,
since it was observed earlier that eRF3 N-terminal part
may be folded incorrectly in bacteria [[18] and our un-
published data]. The purified GST-Itt1p associated with
the glutathione agarose beads was incubated with the
purified bacterially-expressed His6-eRF3, His6-eRF3N2
(eRF3 amino acids 1 – 153), eRF3C (amino acids 254 –
685) and eRF1, as well as with eRF3 isolated from yeast.
Figure 1
A comparison of ammo acid sequences of the Itt1 protein of S. cerevisiae and its best homologues from Schizosaccharomyces
pombe (GenBank CAB65614.1), man (androgen receptor activator ARA54, NP_004281.1) and C. elegans (AAB52683.1).
Sequences were aligned by introducing gaps (...). Conservative amino acids are highlighted in black (cysteines and histidines)
and gray and shown as "consensus". The putative nuclear import signal is underlined. The similarities between the second and
third double zinc finger elements are shown by lines. In the third element, the residues presumably involved in zinc binding are
numbered. In the earlier assignment [17], these are 1,2, &,$ , 3, 4, 5, 6, with $ corresponding to histidine of some other TRIAD
sequences.
  Itt1p-Sc          MALTQFENDLEILRDMYPELEMKSVKVEE....EGEFPQRINGKLLFKISLLADVNIEFGEQHMLLSNLSNECVEFTIYSCHYPDIRRCVVMDIKSLWISTD  
  Itt1p-Sp  MLEVEVESDNKHLVADELIALQSIYPEIHLDGNNYG.....RLNIPVNTESDYFLSFKSPDESTLTDT....IVVRHFPDLVMEFFLPEAYPFNS.PPTFFLKSSWLPLK  
  ARA54-Hs       MSSEDREAQEDELLALASIYDGDEFRKAESVQGGETRIYLDLPQNFKIFVS.GNSNECLQNSG..FEYTICFLPPLVLNFELPPDYPSSS.PPSFTLSGKWLSPT  
F56D2.5-Ce         MTDRDLQIYELEALESVLREKKLAKSSDWSDKNAEIQGIIEVGFDNLYDPTVTIEGTSDSGDQFHLPLDILPPIRLKFHLPNDYPTVS.SPKLELESYWMNQE  
 Consensus                  EL AL S Y E                                  E     G          P  V  F LP  YP  S  P   L S W 
 
  Itt1p-Sc  EKKMLIDKALRLVEETVDMSIEFADSFTSILILIFGFLIDDTAILLFPNGIR.....................................KCLTQDQYDLFKQISEEATLQ  
  Itt1p-Sp  QKRVLTSSLIKLWNE.IHDCVLFDAIEHVRSIATIAFHLPTEMVFPGGFDD............................................LKKEILAFDKNAKLL  
  ARA54-Hs  QLSALCKHLDNLWEEHRGSVVLFAWMQFLKEETLAYLNIVSPFELKIGSQKKVQRRTAQASPNTELDFGGAAGSDVDQEEIVDERAVQDVESLSNLIQEILDFDQAQQIK  
F56D2.5-Ce  QMTSCETELAKICEENQMMEVLFMCYQTIIDLMAQNTPKIINLNEACALNR.....................................QGETIESLKMKILQKEEEAVEE  
 Consensus  Q   L   L  L EE     VLF                                                                        L   IL     A 
 
  Itt1p-Sc  KVSRSNYHCCICMEMEKGVRMIKLPCEN.ANVEHYLCRGCAKSYFTAMIQENRISSVRCP..QCEYKELKLEDFKSYKKMLKALFTPLIPVSFLKEVIDTELCERYEKMF  
  Itt1p-Sp  EFQIRKFQCNVCFDEFNGTD.....CFQLTRCGHVSCQSCLRDYYTMCIQEGMFSQIKCIDLDCGKDAPVLTL..................KELESIVGVQLTNRYKELE  
  ARA54-Hs  CFNSKLFLCSICFCEKLGSE.....CMYFLECRHVYCKACLKDYFEIQIRDGQVQCLNCPEPKCPSVATPG.....................QVKELVEAELFARYDRLL  
F56D2.5-Ce  QFVNTLYDCQVCFESQMGQH.....CIKFQPCSHVFCKSCTFNYYISIAKGFVSKPMSCLAEGCENEAQQG.....................MVQEALGEELFAKYEAHM  
 Consensus   F      C  CF    G       C     C HV C  C   Y    I         C    C   A                           E    EL  RY 
 
  Itt1p-Sc  YNQAATRLS..KYCPYACVTCRRCDSWCTKEDLDDAMIQCQKCHFVFCFDCLHAWHGYNNKCGKKVSLSTDIIEEYLDDTVTSYERKRKLEAKYGRRVLELEVNDYLAEK  
  Itt1p-Sp  EKRRYENDSNIIFCPRSF.....CQGPSKRDP.GQKLAICQKCDFAFCSFCQATWHGDLSPCKLEG.DSKKLVEMYLNYQENEPEKALELEKRYGKRIIDRLVEQVKNDE  
  ARA54-Hs  LQSSLDLMADVVYCPRPC.....CQLPVMQEP.GCTMGICSSCNFAFCTLCRLTYHG.VSPCKVT...AEKLMDLRNEYLQADEANKRLLDQRYGKRVIQKALEEME...  
F56D2.5-Ce  LEKAIREMDDSMECPNEN.....CQMVAYLTDSQRNLVECSYCNYSFCNLCKGTFHG.VSRCKFR...KEDEERIMKEWNEADEAGKEEMYKRYGEKNM.KALEERFL..  
 Consensus               CP        CQ              C  C F FC  C  T HG  S CK                       K  L  RYG R      E 
 
 
        Itt1p-Sc  MLDLAIKKEGSNLQRCPKCKVVVERSEGCNKMKCEVCGTLFCFICGVLLYPEDPYEHFREAYSGCYGRLFEGMPGTET 
        Itt1p-Sp  EAEKWVLLNG...QRCPTCDRVVERIDGCCHMNCL.CGTHFCFLCGAYLMEQNPYKHFNDPVSSCYGMLFASAAEKQRFSENWT 
        ARA54-Hs  .SKEWLEKNS...KSCPCCGTPIEKLDGCNKMTCTGCMQYFCWICMGSLSRANPYKHFNDPGSPCFNRLFYAVDVDDDIWEDEVED 
      F56D2.5-Ce  .NRGWLEENS...KQCPKCLVYIEKDEGCNKMHCTKCNASFCWLCSKTLNNVDPYSHYSEKGS.CNGRLFQGTWVDEEVDEFDWE 
       Consensus      W   N      CP C    E   GCNKM C  C   FC  C   L    PY HF    S C GRLF          E 
                                 1  2         & $  3  4    5  6           7       8 BMC Molecular Biology 2001, 2:9 http://www.biomedcentral.com/1471-2199/2/9
Then unbound proteins were removed by washing, and
GST-Itt1p with associated proteins were eluted and ana-
lyzed by Western blotting using polyclonal antibodies
against eRF3 and eRF1. Itt1p specifically bound eRF1,
eRF3 and eRF3N2, but did not bind the eRF3C fragment
and GST protein (Figure 3). The interaction of Itt1p with
eRF1 and eRF3 was also studied using yeast lysates as a
source of these proteins. Immobilized GST-Itt1p precipi-
tated eRF3 and eRF1 from lysates of cells with the mult-
icopy SUP35 and SUP45 plasmids, but not from wild-
type lysates (data not shown). This probably indicates
that interaction between the studied proteins is relatively
weak.
The suppressor effect of excess Itt1p depends on both 
eRF1 and eRF3 release factors
To test the role of eRF1 in the ITT1 suppressor effect, the
multicopy plasmids with ITT1 and SUP45 were simulta-
neously introduced into the strain 5V-H19. These trans-
formants did not express the suppressor phenotype
(Figure 4). In contrast to eRF1, the overexpression of
eRF3 did not abolish the suppressor effect of the Itt1p
overexpression. It is noteworthy that overexpression of
eRF1 alone does not cause antisuppressor effect [4] and
overproduction of eRF3 does not suppress the ade2-1
UAA mutation in the 5V-H19 strain (data not shown).
Figure 2
The levels of nonsense suppression related to Itt1p overexpression. Suppression efficiency was determined in the strain 1A-
H8-B2 (itt1::LEU2) and its derivative, 1A-H8-B2-R (itt1::LEU2 SUP35-C). The strains carried either one of the plasmids YCplac22-
ITT1 (centromeric ITT1), YEplac112-ITT1 (multicopy ITT1) or pITT1-SUP45 (multicopy plasmid with both ITT1 and SUP45), in
combinations with pUKC815, pUKC817, pUKC818 or pUKC819. The levels of readthrough of UAA (a), UAG (b) or UGA (c)
nonsense codons were determined as described in Materials and Methods. Values are the mean of three independent assays ±
SD. The expression status of ITT1 and other relevant genes is shown below the graph: Single, ITT1 expressed from centromeric
plasmid; Multi, expression of ITT1 or SUP45 from multicopy plasmids; C, chromosomal SUP35-C deletion allele; WT, chromo-
somal SUP35 or SUP45 wild-type alleles.
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These data suggest that eRF1 is a primary target for the
Itt1p inhibition, while the Itt1p interaction with eRF3
may not play an important role in the suppressor effect.
To check the latter, we examined the effect of excess Itt1p
in the strain 1-5V-H19, which encodes only the eRF3 C-
terminal domain unable to interact with Itt1p. This strain
and 5V-H19 were transformed with the multicopy ITT1
plasmid and the suppressor effect was scored by study-
ing growth of transformants on adenine omission medi-
um. The suppression of ade2-1 UAA mutation was
observed in both strains, although the efficiency of sup-
pression was much lower in transformants of 1-5V-H19
(Figure 4). Thus, the interaction of Itt1p with eRF3 could
play a role in the Itt1p suppressor effect.
The influence of eRF1 and eRF3 on the suppressor effect
of elevated Itt1p levels revealed in the strains 5V-H19
and 1-5V-H19 in a plate assay was further quantified in
the strains 1A-H8-B2 and 1A-H8-B2-R containing the
wild-type SUP35 gene and its 5'-deletion SUP35-C allele,
respectively (Figure 2). The absence of the N domain of
eRF3 reduced the readthrough of nonsense codons
caused by multicopy ITT1 approximately 2–3-fold. Ex-
amination of transformants with the pITTI-SUP45 plas-
mid, which carried both ITT1 and SUP45, revealed that
the overexpression of eRF1 completely abolished sup-
pression caused by overexpression of the Itt1 protein.
Discussion
This paper describes a novel protein, Itt1p, involved in
the control of translation termination in yeast. Two lines
of evidence support this conclusion: (i) overexpression of
Itt1p enhances the readthrough of UAA, UAG and UGA
nonsense codons; (ii) Itt1p interacts with both eRF1 and
eRF3 polypeptide chain release factors. It is noteworthy
that in contrast to deletions of SUP45 and SUP35 the
knockout of ITT1 is not lethal and does not noticeably in-
fluence the nonsense codon readthrough. This suggests
that Itt1p is not essential for the release of completed
polypeptide chains from the ribosome.
The suppressor effect of Itt1p was observed at increased
Itt1p to eRF1 ratio, but did not occur when this ratio was
normal, including the case when both proteins were
overexpressed. This suggests that eRF1 experiences
quantitative, rather than qualitative alteration. The sim-
plest explanation of these and other data is that the bind-
ing of Itt1p to eRF1 makes it inactive in translation
termination. It is important that Itt1p is likely to be ex-
pressed at lower level than eRF1. According to published
estimates [19], the difference in CAI of eRF1 (0.334) and
Itt1p (0.127) could mean that eRF1 is expressed at about
3-fold higher level than Itt1p. The role of eRF3 in the
suppressor effect of Itt1p is less clear. The suppressor ef-
fect of excess Itt1p was not affected by overexpression of
eRF3, but was reduced in the presence of N-terminally
truncated eRF3, which does not interact with Itt1p. To
explain this, it is possible to suggest that the interaction
of Itt1p with eRF3 is weaker than with eRF1, but it
strengthens the binding of Itt1p to eRF1/eRF3 complex,
thus enhancing the suppressor effect of Itt1p. However,
the effect of the N-terminally truncated eRF3 can also be
explained by observation that it promotes translation
termination better than complete protein [8]. It may be
difficult to distinguish these two mechanisms and we
consider it likely that both take place.
It is not clear whether the inhibitory effect of Itt1p repre-
sents its main function, or whether it is a consequence of
recruiting eRFs for some function different from the
Figure 3
Itt1p interacts with both eRF3 and eRF1. All proteins were
isolated from E. coli, except eRF3 (S.c.), isolated from S. cere-
visiae. The indicated proteins were incubated with GST-Itt1p
or GST proteins immobilized on glutathione-Sepharose 4B.
Following washing, bound proteins were eluted and analyzed
by Western blotting with polyclonal antibodies against eRF3
and eRF1.BMC Molecular Biology 2001, 2:9 http://www.biomedcentral.com/1471-2199/2/9
translation termination. The second opportunity looks
more appealing, and it is supported by some structural
features of Itt1p. Itt1p belongs to a unique family of zinc
finger proteins called TRIAD. It contains three double
zinc finger elements, one of which belongs to a RING
class [17]. The similarity of Itt1p with its homologues
from other eukaryotes is not high (20–30%), but it spans
the whole length of Itt1p with the cysteines and histi-
dines of zinc finger elements being highly conserved.
This suggests a functional similarity of Itt1p to at least
some TRIAD proteins.
The alignment of Itt1p with its closest homologues (Fig-
ure 1) and other TRIAD proteins (not shown) reveals no-
table similarity of the second and third double zinc finger
elements, manifested in similar spacing of cysteines and
some conserved residues. This is in contrast to the earlier
assignment of the third finger as belonging to a RING
class C3HC4[17]. One cause of this difference is that the
histidine of the proposed RING signature is poorly con-
served (marked $ in Figure 1). On the other hand, highly
conserved histidine and cysteine residues (marked 7 and
8) were disregarded previously [17]. Intriguingly, in our
version the third element contains an odd number of
conserved residues, nine. Either one of the residues is
unimportant for binding zinc (marked &), or there could
be alternative configurations for zinc binding by this ele-
ment.
Many of RING finger-containing proteins bind ubiqui-
tin-conjugating enzymes and are the substrates for E2-
dependent ubiquitination [20]. It was proposed that this
Figure 4
Overexpression of eRF1 and N-terminal truncation of eRF3 inhibits nonsense suppressor phenotype of transformants with
multicopy  ITT1 plasmid. The strain 5V-H19 harboring pairs of plasmids YEplac181-ITTl/YEplacl95, YEplac181/YEplac195,
YEplacl81- ITTl/YEplacl95-SUP45 or YEplacl81-ITTl/YEplacl95-SUP35 and the strain 1-5V-H19 (SUP35-C) with YEplac181-
ITT1/YEplac19 5 or YEplac181/YEplac195 were grown on medium selective for plasmids, patched on SC-Ade and SC+Ade
plates and incubated for three days. The growth of three independently obtained transformants of each strain is shown.BMC Molecular Biology 2001, 2:9 http://www.biomedcentral.com/1471-2199/2/9
mechanism can be used to target the RING-containing
protein or associated proteins for degradation in a regu-
lated manner. If so, the excess Itt1p could cause suppres-
sion by accelerating degradation of eRF3 and eRFl.
However, this is not the case, since the overexpression of
Itt1p did not affect the levels of eRF3 and eRF1. It is also
known that RING finger proteins can be transcriptional
factors [21] and nuclear localization was predicted for
many of the TRIAD proteins [17]. However, only few of
these proteins were functionally characterized. Two of
them are human androgen receptor activator ARA54
(Figure 1) and rat protein kinase C-associated protein
[22,23]. For both proteins it may be suggested that they
function in cytoplasm and nucleus and play a role in
transcription. Itt1p may also be involved in transcription
regulation since two-hybrid analysis has shown that it in-
teracts with the Snf11p transcription factor [24]. This, to-
gether with the fact that Itt1p contains a putative nuclear
import signal (Figure 1), allows to speculate that Itt1p
may perform coupling of translation termination with
transcription of certain genes.
Itt1p is not the only protein that could link translation
termination with other cellular processes in yeast. At
present, two such proteins are known. The first is Upf1p,
which is involved in the control of NMD pathway and
stimulates translation termination probably by binding
to eRF3 and eRF1 release factors [13,14]. Strikingly, this
protein and its partners, Upt2p and Upf3p, are also re-
quired to control the total accumulation of large number
of mRNAs in addition to their role in RNA surveillance,
though mechanisms of such control are unknown [25].
The second is Mtt1p, a homologue of Upf1p, which inter-
acts with both release factors, but is not involved in the
NMD control and inhibits translation termination [16].
This protein has 5'→  3' DNA-dependent helicase activity
and is thought to be involved in chromosome replication
[26–28]. However, the question is still open, whether
such proteins can mediate the interdependence of these
cellular processes.
Conclusions
The data presented in this work show that the increased
expression of the ITT1 (YML068w) gene reduces effi-
ciency of translation termination. The Itt1 protein can
bind to the translation termination factors eRF1 and
eRF3 and we propose that the resulting complex(es) are
incompetent for termination. eRF1 appears to be a pri-
mary target for the inhibition by Itt1p, since the suppres-
sor effect of the excess Itt1p is reverted by overexpression
of eRF1, but not of eRF3. Itt1p possesses a zinc finger do-
main characteristic of the TRIAD proteins of higher eu-
karyotes, and this is a first observation of such protein
being involved in translation. However, the role of this
protein is probably not restricted by translation. Itt1p in-
teracts with the transcriptional factor Snf11 and there-
fore could function in transcription, similarly to some of
its homologues from other species.
Materials and Methods
Genetic methods
We used standard organic (YEPD) and synthetic com-
plete (SC) media for yeast [29] and LB medium for bac-
teria [30]. Appropriate amounts of amino acids, bases,
and antibiotics were added when necessary. The 5'-
fluoroorotic acid (5FOA) medium was prepared accord-
ing to [31]. The final concentration of 5FOA was 400 µg/
ml. All solid media contained 2.0% agar. Yeast cells were
grown at 30°C, and bacteria at 37°C. Standard yeast ge-
netic procedures for mating, sporulation, and tetrad
analysis were used [29]. DNA transformation of yeast
and Escherichia coli cells was performed as described
previously [32,33].
Strains and plasmids
The yeast strains 2G-DM8 (MATα  ade2-144,717 pheA10
his7-1 lys2-l87 trp1-1 ura3-52) and 5V-H19 (MATa
ade2-1 SUQ5 can1-100 leu2-3,112 ura3-52) were de-
scribed in [8]. The strain 1-5V-H19 was obtained by re-
placing the wild-type SUP35 gene of 5V-H19 with the
SUP35-C deletion allele, which encodes amino acids
254-685 of eRF3 [9]. The diploid H8 strain (MA Tα /MA
Ta trp1-289/ trp1-289 leu2-3,112/ leu2-3,112 ura3-52/
ura3-52 his3-∆ 1/ his3-∆ 1) was described in [34]. Con-
struction of other strains is described below. All strains
were [psi]. -
DNA manipulations were carried out by standard proto-
cols [30]. The DH5 α  E. coli strain [supE44 ∆ lac U169 (φ
80  lacZ∆  M15) hsdR17recA1endA1gyrA96 thi-1 relA1]
was used for plasmid construction [30]. To create yeast
genomic library, chromosomal DNA of the 5V-H19 strain
was partially digested with Sau3A and fractionated on
agarose gel. DNA fragments ranging from 6 to 12 kb were
isolated. The ends of chromosomal DNA fragments were
partially filled in with Klenow enzyme and ligated to par-
tially filled in SalI site of the YEplac195 plasmid [35]. The
ligation products were used for E. coli transformation.
The plasmids containing ITT1, SUP45 and SUP35 were
constructed as follows. The 2.7 kb XbaI-HindIII genomic
fragment carrying the ITT1 gene was cloned into the
same sites of pBluescript II KS(+) (Stratagene, USA),
and the resulting plasmid was designated as pITT1. The
ITT1 SacI-HindIII fragment of this plasmid was inserted
into the multicopy vectors YEplac195, YEplacl8l,
YEplac112, with URA3, LEU2 and TRP1 selectable mark-
ers, respectively, and into the TRP1-carrying centromer-
ic vector YCplac22 [35]. The 2.5 kb XhoI-SalISUP45-
csarymg fragment of pEMBLyex4-SUP45 [4] was clonedBMC Molecular Biology 2001, 2:9 http://www.biomedcentral.com/1471-2199/2/9
into the SalI site of YEplacl95 to yield YEplac195-SUP45.
The 2.7 kb SacI-SalIITT1 fragment of the plasmid pITTl
was inserted into the same sites of YEplac195-SUP45 to
obtain the pITTl-SUP45 plasmid. The 3.6 kb XhoI-XbaI
SUP35-carrying fragment of pEMBLyex4-SUP35 [8] was
inserted into the SalIand XbaI sites of YEplac195 which
resulted in the plasmid YEplac195-SUP35.
The construction of the hybrid genes encoding N-termi-
nal fusions of GST (glutathione S-transferase) to eRF1,
eRF3 and eRF3C was described earlier [18,36]. To con-
struct the pGST-ITT1 plasmid encoding GST-Itt1p fusion
protein, the 1.7 kb BamHI-HindIII fragment carrying the
entire ITT1 gene (BamHI site was engineered at the 5'
end of the ITT1 ORF) was cloned into the same sites of
pGEX-2TH, which was obtained from the pGEX-2T plas-
mid (Pharmacia, Sweden) by EcoRI to HindIII replace-
ment. To obtain plasmids expressing His6-eRF3N2 and
His6-eRF3, the SUP35 coding sequence from engineered
BglII site at position-12 before the start codon to BalI site
at codon 154 or XbaI site in the 3' non-coding region,
which was filled-in by Klenow, was cloned into BamHI
and HincII sites of pQE-10 (Qiagen) in-frame and down-
stream of the 6-histidine tag sequence. Both proteins
have N-terminal extension MRGSHHHHHHTDLAT. All
fusion proteins were expressed in the E. coli strain TG1
{supE Hsd∆ 5 thi∆  (lac-proAB) F' [traD36 proAB + lacI q
lacZ M15]}.
The  ITT1 gene was disrupted as follows. The 1.0 kb
EcoRI-XbaI fragment internal to the ITT1 ORF was re-
placed with the 2.0 kb LEU2-carrymg SacI-XbaI frag-
ment of the plasmid pJJ283 [37]. The EcoRI and SacI
ends of these fragments were filled in with Klenow en-
zyme prior to ligation. The obtained plasmid was cleaved
with BclI and HindIII and the obtained 3.6 kb fragment
carrying the itt1::LEU2 d i sru p t i o n  a l le le  w a s u s e d  t o
transform the strain H8. The Ura+ transformant was
designated as H8-B2 and confirmed to be heterozygous
for the ITT1 disruption by Southern blot analysis (data
not shown). The strain 1A-H8-B2 carrying the
itt1::LEU2 allele was obtained as a meiotic segregant of
the diploid H8 heterozygous for the ITT1 disruption al-
lele.
The strain 1A-H8-B2-R was obtained from 1A-H8-B2 by
replacing the wild-type SUP35 gene with the SUP35-C
deletion allele using the integration/excision method
[38]. The pFL44Sc∆ -SUP35C integrative plasmid (lack-
ing the ClaI fragment with 2 µm replication origin) bear-
ing a SUP35-C allele [8] was linearized by SalI site
internal to the SUP35 ORF and integrated into the
SUP35 gene of the strain 1A-H8-B2 by selecting of trans-
formants on uracil omission medium. The Ura + inte-
grants expressing both eRF3 and eRF3C were selected by
Western blotting and placed onto the 5-FOA containing
medium to select for the alternative URA3-SUP35 or
URA3-SUP35-C excision. The obtained Ura- clones of
one integrant were screened by Western blotting to se-
lect a clone expressing only the eRF3C protein (data not
shown).
β -Galactosidase assays of yeast strains transformed with 
the pUKC815/817/181/819 series vectors
The URA3-carrying plasmid pUKC815 encodes a PGKl-
lacZ gene fusion, while the pUKC817, pUKC818 and
pUKC819 plasmids are identical to pUKC815 except that
one of the three termination codons, UAA, UAG and
UGA, respectively, is present in-frame at the junction of
the PGK1 and lacZ genes [39]. Suppression of the in-
frame premature stop codons will result in β -galactosi-
dase activity and the levels of β -galactosidase activity can
therefore be used to quantify the readthrough of non-
sense codons. The nonsense suppression levels were de-
termined as ratio of β -galactosidase activities in the cells
transformed with plasmids pUKC817, pUKC818 and
pUKC819 to that of the transformant with pUKC815. In-
dividual transformants were grown selectively in SC sup-
plemented with the required amino acids and bases to
mid-exponential phase at 30°C.
Preparation of yeast cell lysates
Yeast cultures were grown to OD600 of 1.5, harvested,
washed in water and lysed by vortexing with glass beads
in buffer A (25 mM Tris-HCl [pH 7.4], 100 mM NaCl, 5
mM MgCl2, 1 mM dithiothreitol) containing 1 mM phe-
nylmethylsulfonylfluoride to limit proteolytic degrada-
tion. Cell debris was removed by centrifugation at 15,000
g for 10 min.
Purification of eRF1, eRF3 and eRF3 fragments and assay 
for interaction with immobilized GST-Itt1p
The GST-Itt1p, GST-eRF1, GST-eRF3C fusion proteins
expressed in E. coli and GST-eRF3 expressed in yeast
were isolated by affinity chromatography on glutath-
ione-Sepharose 4B (Pharmacia). The GST extension
from GST-eRF1 and GST-eRF3 was removed with
thrombin (Sigma), and from GST-eRF3C with factor Xa
(Promega), as described [40]. The His6-eRF3 and His6-
eRF3N2 proteins expressed in E. coli were isolated using
TALON resin (Clontech) according to manufacturer's in-
structions. The glutathione-Sepharose 4B resin with im-
mobilized GST-Itt1p was incubated with yeast lysates or
with the purified eRFl, eRF3, eRF3N2 and eRF3C pro-
teins for 2 h at 4°C and then washed with a 40-fold resin
volume of buffer A. Bound proteins were eluted with 2%
SDS and analyzed by Western blotting.BMC Molecular Biology 2001, 2:9 http://www.biomedcentral.com/1471-2199/2/9
Protein gel electrophoresis and Western blot analysis
Protein samples were separated on an SDS polyacryla-
mide gel as described [41] and electrophoretically trans-
ferred to nitrocellulose sheets [42]. Western blots were
probed with polyclonal rabbit anti-eRF3, anti-eRF3C or
anti-eRF1 (a gift of K. M. Jones, University of Kent) anti-
body. Bound antibodies were detected with the Amer-
sham ECL system as instructed by manufacturer.
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